REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC
08/10/2020 14:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20201008:nBw5fsDjXa
Form 8.3 - WILLIS TOWERS WATSON PLC
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the dealings being disclosed relate (Note ORD
2)
Date of dealing 7 October 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
2,455,553 1.91% 465,044 0.36%
(2) Derivatives (other than options):
355,000 0.28% 388,524 0.30%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
TOTAL:
2,810,553 2.18% 853,568 0.66%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 8 211.1150 USD
Purchase 18 211.4416 USD
Purchase 18 210.6400 USD
Purchase 18 211.3541 USD
Purchase 21 211.0138 USD
Purchase 24 211.0004 USD
Purchase 25 210.7900 USD
Purchase 34 211.4502 USD
Purchase 38 211.4847 USD
Purchase 40 211.2206 USD
Purchase 49 211.6024 USD
Purchase 112 210.9957 USD
Purchase 158 211.1588 USD
Purchase 200 211.0350 USD
Purchase 200 211.0300 USD
Purchase 253 210.9026 USD
Purchase 300 211.0750 USD
Purchase 300 211.2098 USD
Purchase 388 211.1307 USD
Purchase 400 210.9775 USD
Purchase 400 211.0550 USD
Purchase 400 210.9857 USD
Purchase 439 210.8814 USD
Purchase 513 211.4102 USD
Purchase 556 211.3061 USD
Purchase 800 211.0800 USD
Purchase 848 211.3559 USD
Purchase 861 211.7159 USD
Purchase 880 211.1134 USD
Purchase 1,059 211.1200 USD
Purchase 1,262 211.3272 USD
Purchase 1,405 211.1367 USD
Purchase 2,700 211.0935 USD
Purchase 2,794 211.3449 USD
Purchase 4,227 211.3826 USD
Purchase 4,270 211.4773 USD
Purchase 6,361 211.5336 USD
Purchase 6,888 211.5273 USD
Purchase 6,941 211.3835 USD
Purchase 12,165 211.1199 USD
Purchase 18,532 211.3241 USD
Purchase 18,535 211.2939 USD
Purchase 26,399 211.1423 USD
Purchase 26,446 210.6591 USD
Purchase 26,446 210.6590 USD
Purchase 126,728 211.1595 USD
Purchase 127,528 211.1590 USD
Sale 48 210.7300 USD
Sale 99 210.4952 USD
Sale 100 210.2200 USD
Sale 100 210.4400 USD
Sale 100 211.0100 USD
Sale 100 211.8600 USD
Sale 101 210.8119 USD
Sale 200 211.4100 USD
Sale 300 211.6500 USD
Sale 405 211.0254 USD
Sale 428 211.2743 USD
Sale 476 211.1387 USD
Sale 607 211.4944 USD
Sale 729 210.8634 USD
Sale 830 210.7236 USD
Sale 878 210.9641 USD
Sale 1,066 210.8689 USD
Sale 1,100 210.8418 USD
Sale 1,502 211.0752 USD
Sale 1,706 211.1930 USD
Sale 1,735 210.9690 USD
Sale 1,995 210.7621 USD
Sale 2,045 211.6852 USD
Sale 2,133 210.8104 USD
Sale 2,537 210.9900 USD
Sale 2,964 211.1195 USD
Sale 3,463 210.9950 USD
Sale 4,820 211.1430 USD
Sale 5,000 211.0829 USD
Sale 5,143 211.4460 USD
Sale 6,480 211.5584 USD
Sale 6,605 211.2978 USD
Sale 7,425 211.0744 USD
Sale 7,767 211.1200 USD
Sale 9,471 211.0998 USD
Sale 9,579 211.5626 USD
Sale 11,768 211.1817 USD
Sale 12,165 211.1199 USD
Sale 12,314 211.1791 USD
Sale 14,638 211.0642 USD
Sale 15,594 211.0423 USD
Sale 17,850 211.1150 USD
Sale 20,688 211.1555 USD
Sale 26,446 210.6590 USD
Sale 38,325 211.3162 USD
Sale 41,942 211.0490 USD
Sale 127,528 211.1590 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 8 October 2020
Contact name Large Holdings Regulatory Operations
Telephone number 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)
View source version on businesswire.com:
https://www.businesswire.com/news/home/20201008005583/en/
(https://www.businesswire.com/news/home/20201008005583/en/)
BARCLAYS PLC
Copyright Business Wire 2020Recent news on Barclays
See all newsREG - Barclays PLC - Director/PDMR Shareholding
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC Empiric Student Prop - Form 8.3 EMPIRIC STUDENT PROPERTY PLC
AnnouncementREG - Barclays PLC Unite Group PLC - Form 8.3 UNITE GROUP PLC, THE
Announcement